Loading...
An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers
Pemetrexed, approved for the treatment of non-small cell lung cancer and malignant mesothelioma, has adverse effects including neutropenia, leucopenia, thrombocytopenia, anemia, fatigue and nausea. The results we report here represent the first genome-wide study aimed at identifying genetic predicto...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3298275/ https://ncbi.nlm.nih.gov/pubmed/22171072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddr583 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|